| Hans-Günter Meyer-Thompson | Hepatitiden
Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results.
Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results.
Gandjour A (2020)
PLoS ONE 15(10): e0236543. doi.org/10.1371/journal.pone.0236543
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236543